Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo

C M Howard1, P P Claudio, G L Gallia

  • 1Department of Pathology, Anatomy, and Cell Biology, Jefferson Medical College, and Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, PA 19102, USA.

Abstract

Insights

RB2/p130 acts as a tumor suppressor gene, significantly reducing tumor mass in mice. This protein inhibits JC virus T-antigen-mediated cell transformation, supporting its role in cancer prevention.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • Retinoblastoma gene family members RB/p105 and p107 are tumor suppressors.
  • Polyomavirus T-antigens inactivate these proteins, leading to tumorigenesis.
  • RB2/p130, another family member, is suspected to be a tumor suppressor.

Purpose of the Study:

  • Directly investigate the tumor suppressor activity of RB2/p130.
  • Utilize a tetracycline-regulated system to control pRb2/p130 expression in JC virus-induced brain tumor cells.
  • Assess the impact of pRb2/p130 on tumor growth in vivo and its interaction with JC virus T-antigen.

Main Methods:

  • Northern blot hybridization for mRNA levels.
  • Immunoprecipitation and Western blot for protein analysis and phosphorylation status.
  • Subcutaneous injection of tumor cells into nude mice to monitor tumor growth with induced pRb2/p130 expression.

Main Results:

  • Induced pRb2/p130 expression reduced tumor mass by 69%.
  • JC virus T-antigen binds hypophosphorylated pRb2/p130.
  • Stimulated pRb2/p130 expression counteracted T-antigen-mediated cellular transformation.

Conclusions:

  • RB2/p130 functions as a tumor suppressor gene.
  • These findings validate the hypothesis of RB2/p130's tumor-suppressive role.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...